电话:
400-7060-959
传真:
+86 10 56315212-8813
电子邮件:
orders@antibodies-online.cn

HSPG2 抗体

HSPG2 适用: 人, 小鼠, Cow, 鱼, 猴, Pig IHC (p), IF, FACS 宿主: 大鼠 Monoclonal A7L6 unconjugated
产品编号 ABIN3023902
发货至: 中国
  • 抗原 See all HSPG2 抗体
    HSPG2 (Heparan Sulfate Proteoglycan 2 (HSPG2))
    适用
    • 28
    • 17
    • 6
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    人, 小鼠, Cow, 鱼, 猴, Pig
    宿主
    • 19
    • 6
    • 6
    大鼠
    克隆类型
    • 20
    • 11
    单克隆
    标记
    • 21
    • 4
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This HSPG2 antibody is un-conjugated
    应用范围
    • 20
    • 13
    • 10
    • 9
    • 8
    • 7
    • 5
    • 4
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (IF), Flow Cytometry (FACS)
    产品特性
    This mAb specifically precipitates heterogeneous material of high MW, identified as perlecan, a major heparan-sulfate proteoglycan (HSPG) within all basement membranes and cell surfaces. It does not cross-react with laminin, fibronectin, or dermatran sulfate proteoglycan. Because of perlecan s strategic location and ability to store and protect growth factors, it has been strongly implicated in the control of tumor cell growth and metastatic behavior. Perlecan possesses angiogenic and growth-promoting attributes primarily by acting as a co-receptor for basic fibroblast growth factor (FGF-2). Suppression of perlecan causes substantial inhibition of neoplastic growth and neovascularization. Thus, perlecan is a potent inducer of neoplasm growth and angiogenesis in vivo and therapeutic interventions targeting this key modulator of tumor progression may improve neoplastic treatment.
    纯化方法
    Protein G affinity chromatography
    免疫原
    A murine EHS laminin preparation was used as the immunogen for the Perlecan antibody.
    克隆位点
    A7L6
    亚型
    IgG2a kappa
    Top Product
    Discover our top product HSPG2 Primary Antibody
  • 应用备注
    Optimal dilution of the Perlecan antibody should be determined by the researcher.

    1. Staining of formalin-fixed tissues requires boiling tissue sections in 10  mM Citrate buffer,  pH 6.0, for 10-20 min followed by cooling at RT for 20 min
    2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Flow Cytometry: 0.5-1 μg/million cells in 0.1ml,Immunofluorescence: 0.5-1 μg/mL,Immunohistochemistry (FFPE): 1-2 μg/mL for 30 min at RT (1),Prediluted format : incubate for 30 min at RT (2)

    限制
    仅限研究用
  • 浓度
    1 mg/mL
    缓冲液
    1 mg/mL in 1X PBS, BSA free, sodium azide free
    储存液
    Azide free
    储存条件
    4 °C,-20 °C
    储存方法
    Store the Perlecan antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
  • 抗原
    HSPG2 (Heparan Sulfate Proteoglycan 2 (HSPG2))
    别名
    Perlecan (HSPG) (HSPG2 产品)
    别名
    HSPG antibody, PLC antibody, PRCAN antibody, SJA antibody, SJS antibody, SJS1 antibody, HSPG2 antibody, AI852380 antibody, Pcn antibody, Plc antibody, per antibody, Per antibody, heparan sulfate proteoglycan 2 antibody, perlecan (heparan sulfate proteoglycan 2) antibody, HSPG2 antibody, hspg2 antibody, Hspg2 antibody
    背景
    This mAb specifically precipitates heterogeneous material of high MW, identified as perlecan, a major heparan-sulfate proteoglycan (HSPG) within all basement membranes and cell surfaces. It does not cross-react with laminin, fibronectin, or dermatran sulfate proteoglycan. Because of perlecan s strategic location and ability to store and protect growth factors, it has been strongly implicated in the control of tumor cell growth and metastatic behavior. Perlecan possesses angiogenic and growth-promoting attributes primarily by acting as a co-receptor for basic fibroblast growth factor (FGF-2). Suppression of perlecan causes substantial inhibition of neoplastic growth and neovascularization. Thus, perlecan is a potent inducer of neoplasm growth and angiogenesis in vivo and therapeutic interventions targeting this key modulator of tumor progression may improve neoplastic treatment.
    途径
    Glycosaminoglycan Metabolic Process, Lipid Metabolism
You are here:
客服